Phytoestrogens/insoluble fibers and colonic estrogen receptor β: randomized, double-blind, placebo-controlled study.
暂无分享,去创建一个
A. Pisani | M. Barone | A. Di Leo | E. Ierardi | D. Piscitelli | M. Principi | M. Comelli | M. Scavo | M. Pricci | S. Tanzi | R. Guido
[1] O. A. Martins,et al. Variations in maternal care alter corticosterone and 17beta-estradiol levels, estrous cycle and folliculogenesis and stimulate the expression of estrogen receptors alpha and beta in the ovaries of UCh rats , 2011, Reproductive biology and endocrinology : RB&E.
[2] F. Bazzoli,et al. Chemoprevention of colorectal cancer: a role for ursodeoxycholic acid, folate and hormone replacement treatment? , 2011, Best practice & research. Clinical gastroenterology.
[3] M. Barone,et al. ERβ expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis , 2010, Scandinavian journal of gastroenterology.
[4] R. Agarwal,et al. Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin. , 2010, Cancer research.
[5] G. Ingravallo,et al. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice. , 2010, Carcinogenesis.
[6] S. Hegazy,et al. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[7] R. Leong,et al. Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer , 2010, Journal of gastroenterology and hepatology.
[8] S. Gruber,et al. Use of hormone replacement therapy and the risk of colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] R. Agarwal,et al. Silibinin Inhibits Established Prostate Tumor Growth, Progression, Invasion, and Metastasis and Suppresses Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Transgenic Adenocarcinoma of the Mouse Prostate Model Mice , 2008, Clinical Cancer Research.
[10] J. Carrier,et al. Estrogen receptor β deficiency enhances small intestinal tumorigenesis in ApcMin/+ mice , 2008, International journal of cancer.
[11] S. Marangi,et al. ER-β expression in large bowel adenomas: Implications in colon carcinogenesis , 2008 .
[12] K. Dahlman-Wright,et al. Review Nuclear Receptor Signaling | The Open Access Journal of the Nuclear Receptor Signaling Atlas Estrogen receptor β: an overview and update , 2022 .
[13] H. Boshuizen,et al. Plasma enterolignan concentrations and colorectal cancer risk in a nested case-control study. , 2007, American journal of epidemiology.
[14] E. Feskens,et al. Relation between plasma enterodiol and enterolactone and dietary intake of lignans in a Dutch endoscopy-based population. , 2007, The Journal of nutrition.
[15] B. Aggarwal,et al. Anticancer potential of silymarin: from bench to bed side. , 2006, Anticancer research.
[16] J. Frasor,et al. Impact of Estrogen Receptor β on Gene Networks Regulated by Estrogen Receptor α in Breast Cancer Cells , 2006 .
[17] Shin-Da Lee,et al. Apoptotic effects of over-expressed estrogen receptor-beta on LoVo colon cancer cell is mediated by p53 signalings in a ligand-dependent manner. , 2006, The Chinese journal of physiology.
[18] J. Gustafsson,et al. Estrogen receptors alfa (ERα) and beta (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11 , 2005, Oncogene.
[19] M. Wargovich,et al. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). , 2005, Carcinogenesis.
[20] V. Speirs,et al. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. , 2005, Oncology reports.
[21] H. Jarry,et al. Silymarin is a selective estrogen receptor β (ERβ) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats , 2003, The Journal of Steroid Biochemistry and Molecular Biology.
[22] A. Papavassiliou,et al. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. , 2003, European journal of cancer.
[23] M. Barone,et al. Distribution of Estrogen Receptor Subtypes, Expression of Their Variant Forms, and Clinicopathological Characteristics of Human Colorectal Cancer , 2002, Digestive Diseases and Sciences.
[24] F. Gannon,et al. Human estrogen receptor-α: regulation by synthesis, modification and degradation , 2002, Cellular and Molecular Life Sciences CMLS.
[25] Takuji Tanaka,et al. Dietary Conjugated Linolenic Acid Inhibits Azoxymethane‐induced Colonic Aberrant Crypt Foci in Rats , 2002, Japanese journal of cancer research : Gann.
[26] P. Albert,et al. Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial. , 2001, Journal of the National Cancer Institute.
[27] A. Di Leo,et al. Estrogens and colorectal cancer. , 2001, Current drug targets. Immune, endocrine and metabolic disorders.
[28] B. O’Malley,et al. Proteasome-dependent degradation of the human estrogen receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Barone,et al. Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. , 1987, Gastroenterology.
[30] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[31] H. Adlercreutz,et al. Dietary lignins are precursors of mammalian lignans in rats. , 2004, The Journal of nutrition.
[32] I. J. Lynch,et al. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. , 2001, Cancer research.